Imunon
IMNN | NASDAQ
$0.59
-$0.04 (-6.20%)
At close: Nov 16, 2026, 4:00 PM ET
$0.59
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:46 PM ET
Imunon Company Profile
Company profile explainedCompany Profile
Imunon, Inc. is a clinical-stage biotechnology company dedicated to the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. The company's pipeline features GEN-1, a DNA-based immunotherapy specifically designed for the localized treatment of ovarian cancer, and ThermoDox, a proprietary heat-activated liposomal formulation of doxorubicin, currently in development for various cancer indications. Additionally, Imunon possesses two feasibility-stage platform technologies aimed at creating nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Established in 1982 and based in Lawrenceville, New Jersey, the firm was known as Celsion Corporation before rebranding to Imunon, Inc. in September 2022.
Key Executives
| Name | Position |
|---|---|
| Stacy R. Lindborg | President, Chief Executive Officer & Director |
| Douglas V. Faller | Chief Medical Officer |
| Joshua Blacher | Interim CFO, Principal Financial Officer & Principal Accounting Officer |
| Kristin Longobardi | Senior Vice President of Strategic Operations |
| Michael H. Tardugno | Executive Chairman |
| Stephen G. Machatha | Senior Vice President of Technical Operations |
| Susan Mary Eylward | General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 28, 2026 | S-1/A | [Amend] Filing |
| Oct 27, 2026 | 4 | Filing |
| Oct 27, 2026 | 4 | Filing |
| Oct 27, 2026 | 4 | Filing |
| Oct 27, 2026 | S-1 | Filing |
| Oct 27, 2026 | 8-K | Current Report |
| Oct 21, 2026 | 8-K | Current Report |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
Imunon
| Country | United States |
| IPO Date | Mar 1, 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 20 |
| CEO | Stacy R. Lindborg |
Contact Details
997 Lenox Drive Lawrenceville,
New Jersey 08648 United States
Stock Details
| Ticker Symbol | IMNN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000749647 |
| CUSIP Number | 15117N701 |
| ISIN Number | US15117N7012 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove IMNN